(Q43938508)

English

Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease (English)

1 reference

Europe PubMed Central

28 November 2017

Christopher G. Goetz

1

object named as

Christopher G Goetz

1 reference

Europe PubMed Central

28 November 2017

2

object named as

Sue Leurgans

1 reference

Europe PubMed Central

28 November 2017

Parkinson Study Group

4

object named as

Parkinson Study Group

1 reference

Europe PubMed Central

28 November 2017

author name string

Rema Raman

3

1 reference

Europe PubMed Central

28 November 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

28 November 2017

Movement Disorders

1 reference

Europe PubMed Central

28 November 2017

17

1 reference

Europe PubMed Central

28 November 2017

283-288

1 reference

Europe PubMed Central

28 November 2017

2

1 reference

Europe PubMed Central

28 November 2017

Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10024

21 January 2018

Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10024

21 January 2018

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10024

21 January 2018

Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group III.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10024

21 January 2018

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10024

21 January 2018

Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10024

21 January 2018

Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10024

21 January 2018

Objective changes in motor function during placebo treatment in PD

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10024

21 January 2018

Pramipexole in patients with early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10024

21 January 2018

Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study Group

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10024

21 January 2018

Identifiers

10.1002/MDS.10024

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43938508&oldid=2104520592"